[
    [
        {
            "time": "2020-03-15",
            "original_text": "Coronavirus fears sparks market swings",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "fears",
                    "market",
                    "swings"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Coronavirus fears sparks market swings",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-10",
            "original_text": "VENCLEXTA® with Rituximab, a Treatment for Patients With Chronic Lymphocytic Leukemia (CLL), now reimbursed in British Columbia",
            "features": {
                "keywords": [
                    "VENCLEXTA",
                    "Rituximab",
                    "Treatment",
                    "Chronic Lymphocytic Leukemia",
                    "reimbursed",
                    "British Columbia"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "VENCLEXTA® with Rituximab, a Treatment for Patients With Chronic Lymphocytic Leukemia (CLL), now reimbursed in British Columbia",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2022-04-20",
            "original_text": "FORM 8.3 - ABBVIE INC - Amendment",
            "features": {
                "keywords": [
                    "FORM 8.3",
                    "ABBVIE INC",
                    "Amendment"
                ],
                "sentiment_score": 0.0,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "financial",
                    "regulatory"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "FORM 8.3 - ABBVIE INC - Amendment",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 9
            }
        }
    ]
]